BREAST CARCINOMA Flashcards

(42 cards)

1
Q

Describe/ summarise basics:

A
  • Can be ductal (arising from milk ducts) or lobular (originating from lobules).
  • They can be in situ or invasive.
  • Paget’s disease is an infiltrating carcinoma of the nipple epithelium (represents 1% of all breast cancers).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 main types?

A

DCIS: Ductal carcinoma in situ
LCIS: Lobular carcinoma in situ (isn’t malignant, but are cancerous changes)
Paget’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lifetime risk of UK females developing breast cancer

A

1 in 8/9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common cause of lump in what age group

A

> 60 (postmenopausal),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How old are most people with breast cancer?

A

can affect women of any age (most commonly >50)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What % of cases are male?

A

Only 1% of cases are male.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How common is the cancer in women?

A

Most common cancer in women in the world

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How common is death from this cancer?

A

2nd most common cause of death from cancer in UK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the aetiology?

A

Over-proliferation of cells in either the lobules or ducts of the breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the genetic risk factors?

A

BRCA1/2 genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What % of women with BRCA1 develop breast cancer by 70?

A

55-65% of women with the BRCA1 mutation will develop breast cancer by the age of 70,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What % of women with BRCA2 develop breast cancer by 70?

A

45% of women with inherited BRCA2 will develop breast carcinoma by the same age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the risk factors?

A
•	Female sex
•	Old age
•	Smoking
•	Previous history
•	Family history
•	Genetics – BRCA1, BRCA2 and TP53 mutations carry very high risk
•	No children
•	Uninterupted oestrogren receptors:
o	Nulliparity
o	Early menarche
o	Late menopause
o	1st pregnancy >30yrs
o	HRT
o	Obesity (fat produces small amounts of oestrogen)
o	Not breastfeeding
•	Radiation to chest (even small doses)
•	High alcohol intake
•	Men with Klinefelter’s syndrome
•	Gynaecomastia
•	Adult height
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is most common presentation?

A

Painless lump in breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

4 most common symptoms

A
  • Lump (80%)
  • Nipple change (10%)
  • Skin contour changes (5%)
  • Nipple discharge (3%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is a lump likely to present?

A

painful in 20% - hard, irregular, fixed, painless, skin dimpling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is skin likely to present?

A

dimpling or thickening of the breast skin, inverted nipple, bloody discharge, eczematous patch of skin on the nipple and surrounding areola

18
Q

What % of all lumps aren’t malignant?

19
Q

Other symptoms

A
  • Breast pain/mastalgia alone uncommon
  • Bloody nipple discharge – intraduct carcinoma
  • Swelling or lumps in the armpit may also be noticed (axillary sentinel node involvement).
  • Change in shape or size of breast
  • Rarely (most common in advanced inflammatory carcinoma) breast mastalgia (pain) may develop.
20
Q

Signs

A
  • Peau d’orange
  • Skin ulceration
  • Nipple inversion
  • Gross deviation
  • Discharge (clear – concerning because cysts don’t usually discharge/bloody), tethered lump (to skin above or chest wall), hard and non-tender lump, nodes feel matted and fixed together/to other structures in axillary involvement.
  • Fixity to pectoral muscles (engage muscles when examining on that side).
21
Q

Where might it metastasise?

A

bone, liver, brain, lungs – examine for hepatomegaly/abdominal pain. .

22
Q

Other non-breast symptoms?

A

Tender spine (bone), breathlessness (respiratory symptoms), headaches and cognitive symptoms

23
Q

Investigations - triple assessment

A
  1. clinical examination
  2. radiology (ultrasound <35 years, mammogram >35years),
  3. histology/cytology (core biopsy – can be ultrasound guided).
Mammography
Fine needle aspiration
Core biopsy
Staged using TNM
Can also do USS of breast and surrounding lymph nodes
24
Q

Cystic lumps are aspirated, any residual mass is biopsied and the aspirate is studied - what do the results mean?

A

Clear aspirate is discarded and the patient can be reassured (more emphatically with no family history and biopsy shows non-proliferative lesion) and discharged from hospital. Bloody aspirate is sent to cytology for assessment.
Solid lumps undergo a core biopsy – any clear fluid is a reassuring sign of a simple cyst, but otherwise malignancy is expected.

25
What does T0 - T4 mean?
TO - no primary tumour, or tumour in situ T1 - 0-2cm T2 - 2-5cm T3 - >5cm T4 - tumour of any size with extension to chest wall
26
What does N0 - N3 mean?
N0 - no lymph node metasteses N1 - cancer cells present in 1-3 axillary lymph nodes - lymph node tumour >2mm N2 - cancer cells present in 4-9 axillary lymph nodes N3 - cancer cells in infra-supra-clavicular lymph nodes
27
What does M0-M1 mean?
M0 - No evidence of cancer metastasis | M1 - Cancer found in other areas of the body
28
What surgical treatment is offered?
Wide local excision or mastectomy with radiotherapy followed by breast reconstruction.
29
What are the indications for total mastectomy?
tumour >4cm in diameter, central site of any considerable size, multi-focal cancer (ILC most commonly), widespread DCIS in one breast, recurrence, BRCA 1/2 genes indicated, patient requests!
30
What are the indications for wide local excision or lumpectomy?
<4cm in diameter, not involved with central structures, one tumour discovered.
31
When do we use Tamoxifen?
Adjuvant hormonal therapy if the tumour is positive for hormonal receptors → Tamoxifen.
32
When do we use Herceptin?
Herceptin can be used in those expressing HER2 gene.
33
When do we use adjacent chemotherapy?
Adjuvant chemotherapy required for patients with endocrine unresponsive tumours.
34
What are the risks of surgery?
wound infection, haematoma, excessive bleeding, GA problems.
35
What do they do with HER2 results?
Younger patients get immunochemistry test for HER2 receptors (scored 0-infinity) 1 or less = no HER2 receptors present 2-3 = unsure → do FISH genetic test for HER2 (more expensive!) 3+ = HER2 positive, treat with supplementary Herceptin
36
Risks of short term chemotherapy?
hair loss, appetite loss, nausea and vomiting, diarrhoea, mouth sores, decrease in all blood cells→ fatigue, infection susceptibility, increased bruising and bleeding. Heart and nerve damage are transient but can be permanent!
37
Risk of long-term chemotherapy?
infertility (ovarian damage), bring on menopausal symptoms, decreased menstruation, osteoporosis, leukaemia, chemo-brain (mind fog – poor short term memory and poor concentration) can last a few years.
38
Risks of radiotherapy?
pericarditis, pneumonitis and fractured ribs, redness of skin, discomfort and swelling, tiredness, may affect potential for reconstruction (skin taught), skin pigmentation.
39
Endocrine agents as a treatment
all aim to decrease oestrogen activity in oestrogen receptor positive tumours. Tamoxifen is an oestrogen receptor blocker (5 year course) – can cause uterine cancer, look for vaginal bleeding. Aromatase inhibitors – Anastrasol is aimed as oestrogen in the periphery in post-menopausal women. Pre-menopausal oestrogen positive women can have an ovarian ablation.
40
Differentials
Fibrocystic breast disease Lump – fibroadenoma, cysts, fat necrosis, abscess Lump, discharge and nipple retraction – Duct ectasia (Slit inversion – periductal mastitis)
41
Complications
Chemo: infection, fatigue, bruising, bleeding, sleep disturbances Psychological: depression, fear, sadness, feelings of isolation, sleep disturbances. Radiation: inflamed lung tissue, heart damage, secondary cancers Hormone therapy: effects of low oestrogen I.e. Osteoporosis Mastectomy: temporary swelling of breast, breast tenderness, hardness due to scar tissue, wound infection or bleeding, lymphedema, phantom breast pain
42
Prognosis
Depends on biological characteristics of the cancer and the patient and on appropriate therapy.